Press Release

Fourteen government agencies, including the Financial Services Commission, have selected 547 small and medium-sized enterprises (SMEs) and middle-market companies as the second cohort of "Innovation Premier 1000" firms for 2026. These selected companies will receive tailored financial and non-financial incentives from policy finance institutions, as well as special benefits through various government support programs, until the end of 2027. "Innovation Premier 1000" is a pro

Statistical Significance of K-VABS-II Scores Confirmed in Confirmatory Clinical Trial Across 5 Institutions; MFDS Manufacturing Certification Obtained... Designed for Repeated Home-Based Training and Parental Involvement Korea's first cognitive behavioral therapy (CBT)-based digital medical device for children and adolescents with Autism Spectrum Disorder (ASD) and Social Communication Disorder (SCD) has arrived. Neudive announced on the 1st that 'Buddy-in' has obtained digit

[The Fair] Reporter Jun-gyu Choi = Hyundai Marine & Fire Insurance is accelerating its efforts to discover innovative early intervention solutions for children with developmental delays and developmental disabilities. The company announced on the 19th that it has selected the final 12 teams to advance to the SPACE-1 stage of its social contribution project, the 'Children's Heart Expedition.' The 'Children's Heart Expedition' is a large-scale three-year project sponsored by Hy

The Korea Brain Research Institute announced on the 17th that the 'Autism Spectrum Disorder (ASD) Digital Medical Device,' jointly developed by Dr. Min-young Jung of the Cognitive Science Research Group and digital healthcare startup Neudive, has obtained the 'New Excellent Technology (NET)' certification designated by the Ministry of Health and Welfare. Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by difficulties in social interaction and com

Research Team Led by Professor Yu-suk Jung of Samsung Seoul Hospital Publishes Treatment Results for 38 Adolescents Using NDTx-01Improvements in Social Adaptation and Daily Living Skills... Professor Yu-suk Jung: "A Contribution to Helping Them Grow as Members of Society" [Medical Tribune · Ilgan Bosa = Reporter Hyun-gi Kim] Mobile game-based digital therapy has been shown to help improve social skills in children and adolescents with Autism Spectrum Disorder (ASD) or Social

The Ministry of Health and Welfare (Minister Gyu-hong Jo) and the Korea National Enterprise for Clinical Trials (KONECT, Chairman In-seok Park) held the '2025 World Clinical Trials Day Commemoration Event' on the 21st at Dongdaemun Design Plaza (Seoul-On Video Studio). World Clinical Trials Day was established to commemorate the first modern clinical trial conducted on May 20, 1747, by British Royal Navy surgeon James Lind, who tested treatments for scurvy on sailors during a

Baekseok University announced on the 20th that its Graduate School of Education has signed a mutual cooperation MOU with Neudive Co., Ltd. The signing ceremony was held on the 17th at the small conference room of the Baekseok Vision Center on the Seoul campus, with attendees including Su-kyung Jeong, Dean of the Baekseok University Graduate School of Education, and Sung-ja Cho, CEO of Neudive. Under the agreement, the two institutions will cooperate in the following areas: ▲

The Korea Brain Research Institute signed a business agreement with Neudive Co., Ltd., a company specializing in the development of digital therapeutics, on the 10th at the Korea Brain Research Institute in Dong-gu, Daegu, for 'Mechanism Research and Medical Device Development of Digital Therapeutics for Brain Developmental Diseases.' The Korea Brain Research Institute and Neudive Co., Ltd. will join forces in the areas of pathogenic mechanism research for overcoming brain di

Neudive (CEO Sung-ja Cho) and the SeeD Special Education Digital Education Association (President Ji-hun Ahn) signed a Memorandum of Understanding (MOU) on the 24th for the development and application of special education digital learning materials, reaffirming their commitment to advancing the field of special education. Neudive is at the forefront of developing innovative digital solutions for the healthy lives of neurodivergent individuals and their families. In May 2024,

Neudive (CEO Sung-ja Cho), a provider of innovative digital solutions for neurodiversity, garnered global attention by winning the Innovation Award at CES 2025. The award-winning product is 'Buddy-in,' a digital therapeutic for children and adolescents with Autism Spectrum Disorder (ASD) and Social Communication Disorder (SCD). Ji-hun Choi, Editor-in-Chief of AVING News and a former CES 2024 Innovation Award judge, conducted an in-depth interview with Neudive CEO Sung-ja Cho,

[Las Vegas, USA = AVING News] Neudive (CEO Sung-ja Cho) participated on the 5th (local US time) in 'CES Unveiled,' the global media event held ahead of the official opening of CES 2025. Neudive is a company that develops and provides digital solutions to assist individuals with social communication disorders and neurodivergent conditions, including Autism Spectrum Disorder, intellectual disabilities, and ADHD. Since its founding in February 2022, the company has been demonstr

CES 2025 Innovation Award WinnerNeudive 'Buddy-in' – Opening a New Chapter for Neurodivergent Individuals and Their Families Through Digital Health Innovation Neudive Co., Ltd. (CEO Sung-ja Cho) unveiled 'Buddy-in' at the CES 2025 Seoul Integrated Pavilion and received the Innovation Award in the Digital Health category. A member of Seoul BioHub, Neudive is a health-tech company dedicated to providing accessible therapeutic solutions for neurodivergent individuals — including

The National IT Industry Promotion Agency (NIPA) held a launch event on the 12th at the El Tower in Yangjae with the six newly selected consortiums for the '2024 AI-Based Medical System Digital Transformation Support' project. The Ministry of Science and ICT and NIPA have been running a digital transformation support project for public medical institutions since last year, aimed at bridging public and regional healthcare gaps and improving the quality of medical services. Con

Including Hippo T&C Consortium for Managing ADHD and Depression through Digital Therapeutics (Seoul = Yonhap News) Reporter Sung-mi Jo = The National IT Industry Promotion Agency (NIPA) announced on the 15th that six new consortiums, including the Deepnoid consortium, have been selected as recipients of support for the AI-based medical system digital transformation project. The Ministry of Science and ICT and NIPA have been supporting digital transformation projects for publi

[Rapportian] Neudive, founded in 2022, is developing a social skills improvement 'Digital Therapeutic' (DTx) for children and adolescents with neurodevelopmental conditions including Autism Spectrum Disorder and Social Communication Disorder (SCD). The company's product under development, 'NDTx-01 Buddy-in,' is a digital therapeutic aimed at improving social situational awareness and interaction in children and adolescents with Autism Spectrum Disorder or Social Communication

The results of an exploratory clinical trial of a social skills improvement digital therapeutic for children and adolescents with Autism Spectrum Disorder and Social Communication Disorder were presented as an oral presentation at the 2024 Spring Academic Conference of the Korean Neuropsychiatric Association. The primary safety and efficacy results of NDTx-01 (Buddy-in), a cognitive therapy software in which 39 subjects were enrolled across Samsung Seoul Hospital, Seoul St. M

Neudive's 'Autism Spectrum Disorder Social Skills Digital Therapeutic,' Buddy-in, was included as one of two products featured in the Digital Therapeutics Potential Value and Impact Assessment Research Report published in December 2023 by the National Evidence-based Healthcare Collaborating Agency (NECA) and the Korea Health Industry Development Institute (KHIDI). The selection was evaluated based on digital healthcare policy demand and domestic market entry potential. The re

Neudive was selected in October 2023 for a TIPS Standard Project under the theme of "Development of a Digital Therapeutic Device for Improving Social Interaction Linked to Social Situational Awareness Assessment in Children with Autism Spectrum Disorder." With Daewoong Pharmaceutical as the TIPS managing company, the primary research objectives are the advancement of the social skills assessment software BuddyPlan and the development of a digital therapeutic device that refle

The New Health Technology Assessment Division of the National Evidence-based Healthcare Collaborating Agency (NECA, Acting President Pil-sang Heo) announced that it will be hosting a relay seminar to strengthen international exchange in the field of digital therapeutics (DTx), sharing successful strategies for health technology assessment and market entry from Germany's DiGA and the UK's NHS/NICE with the domestic industry. In June, NECA held meetings with the Digital Therape

Neudive participated in the '2023 International Advanced Medical Device and Medical Industry Exhibition (KOAMEX 2023),' held over three days from Friday, June 30 to Sunday, July 2 at EXCO in Daegu. Neudive, a developer of digital solutions for the treatment of Autism Spectrum Disorder in children and adolescents that relocated its headquarters to Daegu this year, is participating in the digital healthcare validation support project worth 3 billion KRW annually secured by K-ME